Cellular distribution of tumour suppressor protein p53 and high-risk human papillomavirus (HPV)-18 E6 fusion protein in wild-type p53 cell lines

Journal of International Medical Research

Volumn 36, Issue 5, 2008, Pages 1015-1021

  Sun, L ^a   Zhang, G ^a   Li, Z ^a   Lei, T ^a   Huang, Chen ^a   Song, T ^a   Si, L ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cytoplasm; Green fluorescent protein; HPV 18 E6; Human papillomaviruses; Nuclei; p53; Tumour suppressor protein

Indexed keywords

GREEN FLUORESCENT PROTEIN; PROTEIN E6; PROTEIN P53; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; HYBRID PROTEIN; ONCOPROTEIN; TP53 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WILD TYPE; GENETICS; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL NUCLEUS; DNA-BINDING PROTEINS; GREEN FLUORESCENT PROTEINS; HUMANS; ONCOGENE PROTEINS, VIRAL; RECOMBINANT FUSION PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 54449093454     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600519     Document Type: Article

References (23)

1. zur Hausen H: Papillomoviruses in human cancer. Cancer 1987; 59: 1692-1696.
2. Scheffner M, Werness BA, Huibregtse JM, et al: The E6 oncoprotein encoded by human Papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 21: 1129-1136.
3. Shen ZY, Cen S, Xu LY, et al: E6/E7 genes of human papilloma virus type 18 induced immortalization of human fetal esophageal epithelium. Oncol Rep 2003; 10: 1431-1436.
4. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-79.
5. el-Deiry WS, Tokino T, Velculascu VE, et al: WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
6. Kastan MB, Zhan Q, el-Deiry WS, et al: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587-597.
7. Sherman L, Schlegel R: Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J Virol 1996; 70: 3269-3279.
8. Liang XH, Volkmann M, Klein R, et al: Colocalization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Oncogene 1993; 8: 2645-26S2.
9. Tao M, Kruhlak M, Xia S, et al: Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells. J Virol 2003; 77: 13232-13247.
10. Hiraiwa A, Kiyono T, Segawa K, et al: Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells. Virology 1993; 192: 102-111.
11. Chalfie A, Tu Y, Euskirchen G, et al: Green fluorescent protein as a marker for gene expression. Science 1994; 263: 802-805.
12. Bernat Al, Massimi P, Ranks L: Complementation of a p300/CBP defective-binding mutant of adenovirus E1a by human papillomavirus E6 proteins. J Gen Virol 2002; 83: 829-833.
13. Gross-Mesilaty S, Reinstein E, Bercovich B, et al: Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc Natl Acad Sci USA 1998; 95: 8058-8063.
14. Ronco LV, Karpova AY, Vidal M, et al: Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 1998; 12: 2061-2072.
15. Kumar A, Zhao Y, Meng G, et al: Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol Cell Biol 2002; 22: 5801-5812.
16. Hollstein M, Rice K, Greenblatt MS, et al: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 1994; 22: 3551-3555.
17. Levine AJ: P53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331,
18. Xinarianos G, Liloglou T, Prime W, et al: p53 status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinoma. lnt J Cancer 2002; 101: 248-252.
19. Kawamata H, Omotehara F, Nakashiro K, et al: Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage. Int J Oncol 2007; 30: 1089-1097.
20. Nikolaev AY, Li M, Puskas N, el al: Parc: a cytoplasmic anchor for p53. Cell 2003; 112: 29-40.
21. Mantovani F, Banks L: The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 2001; 20: 7874-7887.
22. Li X, Coffino P: High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J Virol 1996; 70: 4509-4516.
23. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-79.